The use of calcium gluconate priorto verapamil in infants with paroxysmal supraventricular tachycardia
Authors:
Open Access
- 1 November 1984
- journal article
- case report
- Published by Wiley in Clinical Cardiology
- Vol. 7 (11) , 613-616
Abstract
Verapamil is a useful drug for treating supraventricular tachycardia; however, severe side effects occasionally have been reported in infants. We describe here our experience with the use of a 10 percent solution of intravenous calcium gluconate prior to the use of verapamil in infants with paroxysmal supraventricular tachycardia. In all the attacks verapamil converted the supraventricular tachycardia to sinus rhythm. We feel that calcium gluconate injected previous to verapamil can avoid the negative inotropic effects without interfering with the antiarrhythmic properties of verapamil.Keywords
This publication has 14 references indexed in Scilit:
- Editorial note Intravenous calcium and verapamil — when the combination may be indicatedInternational Journal of Cardiology, 1983
- The use of calcium with verapamil in the management of supraventricular tachyarrhythmiasInternational Journal of Cardiology, 1983
- Treatment of paroxysmal supraventricular tachycardia in infancy with digitalis, adenosine-5'-triphosphate, and verapamil: a comparative study.Circulation, 1982
- Effects of verapamil on supraventricular tachycardia in childrenThe American Journal of Cardiology, 1981
- Verapamil in the treatment of paroxysmal supraventricular tachycardia in infants and childrenThe Journal of Pediatrics, 1981
- Experimental studies on the pathogenesis of asystole after verapamil in the dogThe American Journal of Cardiology, 1979
- Effect of verapamil in infants with paroxysmal supraventricular tachycardia.Circulation, 1979
- VerapamilDrugs, 1978
- Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome.Heart, 1974
- Immediate Effects of Intravenous Verapamil in Cardiac ArrhythmiasBMJ, 1972